Diagnosis-based risk adjustment for medicare prescription drug plan payments.

Publisher: U.S. Health Care Financing Administration Country of Publication: United States NLM ID: 7909994 Publication Model: Print Cited Medium: Print ISSN: 0195-8631 (Print) Linking ISSN: 01958631 NLM ISO Abbreviation: Health Care Financ Rev

Publication: [winter 1988] - : Baltimore, MD : U.S. Health Care Financing Administration
Original Publication: [Washington, D.C. : U.S. Dept. of Health, Education, and Welfare, Health Care Financing Administration, Office of Research, Demonstrations, and Statistics], 1979-

Diagnosis-Related Groups* ; Insurance, Pharmaceutical Services* ; Medicare*; Drug Prescriptions/*economics ; Risk Adjustment/*methods; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; United States

The 2003 Medicare Prescription Drug, Improvement, and Modernization Act (MMA) created Medicare Part D, a voluntary prescription drug benefit program. The benefit is a government subsidized prescription drug benefit within Medicare. This article focuses on the development of the prescription drug risk-adjustment model used to adjust payments to reflect the health status of plan enrollees.

Med Care. 2001 Nov;39(11):1188-202. (PMID: 11606873)
Health Care Financ Rev. 2003 Winter;25(2):37-46. (PMID: 15124376)
Med Care. 2005 Jan;43(1):34-43. (PMID: 15626932)

Date Created: 20070829 Date Completed: 20070920 Latest Revision: 20220321

20250114

PMC4195001

17722748